The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

Among the most widely known forms is CAR T cell therapy, where T cells are genetically engineered to recognise and attack cancer cells ... to produce CD5-targeted nanoparticles – designed to seek out ...

A new technique lets researchers make many more of the particles much faster, using consistent practices that meet safety ...

For roughly 400 years, microscopes have allowed us to observe increasingly smaller details. Today's most advanced instruments ...

Human exposure to toxic particles drives various diseases. Examples include gout, an acute arthritis driven by monosodium ...

The silica nanoparticles were conjugated to transferrin, which promoted particle accumulation in cancerous cells, and 3,4,3-LI (1,2-HOPO), a chelator with high selectivity and binding affinity for ...

Previously, we discovered a novel class of compounds (e.g., quinazolinediones, QDs) that exert their cytotoxic effects by modulating ROS-mediated cell signaling. Herein, we prepared novel ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells.

Next steps include designing coatings that stay inert in cells or steering particles away from RuBisCO-binding areas. With that knowledge, future nanoparticles could nourish crops, fight pests, and ...

The CancerVax platform is designed to harness the body’s existing immunity to detect, mark, and kill cancer cells with precision. At the core of the platform are nanoparticles that operate via a ...